about
Cytomegalovirus-induced immunopathology and its clinical consequencesCytomegalovirus infection in transplant recipientsCMV: Prevention, Diagnosis and TherapyDirect and Indirect Effects of Cytomegalovirus-Induced γδ T Cells after Kidney TransplantationCytomegalovirus in human brain tumors: Role in pathogenesis and potential treatment optionsDeceased donor risk factors influencing liver transplant outcomeThe role of the T cell in age-related inflammationAntiviral drug resistance of human cytomegalovirus.Perivascular stromal cells as a potential reservoir of human cytomegalovirus.Outcomes and prognostic factors of non-HIV patients with pneumocystis jirovecii pneumonia and pulmonary CMV co-infection: A Retrospective Cohort Study.Characterization of 3' termini of human cytomegalovirus UL138-UL145 transcripts in a clinical strain.Cytomegalovirus viraemia and mortality in renal transplant recipients in the era of antiviral prophylaxis. Lessons from the western Australian experience.Childhood environments and cytomegalovirus serostatus and reactivation in adults.Cytomegalovirus infection leads to microvascular dysfunction and exacerbates hypercholesterolemia-induced responses.An analysis of regulatory T-cell and Th-17 cell dynamics during cytomegalovirus replication in solid organ transplant recipientsPlatelets, acting in part via P-selectin, mediate cytomegalovirus-induced microvascular dysfunction.Randomized trial of valganciclovir versus valacyclovir prophylaxis for prevention of cytomegalovirus in renal transplantation.Cytomegalovirus infection and risk of Alzheimer disease in older black and white individuals.Effects of donor/recipient human leukocyte antigen mismatch on human cytomegalovirus replication following liver transplantationCytomegalovirus (CMV) seropositivity decreases B cell responses to the influenza vaccine.Single Chain Antibodies Against gp55 of Human Cytomegalovirus (HCMV) for Prophylaxis and Treatment of HCMV Infections.Cytomegalovirus Infection Leads to Development of High Frequencies of Cytotoxic Virus-Specific CD4+ T Cells Targeted to Vascular Endothelium.Inflammaging decreases adaptive and innate immune responses in mice and humansGanciclovir prophylaxis improves late murine cytomegalovirus-induced renal allograft damage.Epigenetic control of cytomegalovirus latency and reactivation.Cytomegalovirus infections in solid organ transplantation: a review.γδ T Cell-Mediated Immunity to Cytomegalovirus Infection.Human cytomegalovirus detection by real-time PCR and pp65-antigen test in hematopoietic stem cell transplant recipients: a challenge in low and middle-income countries.Cytomegalovirus-associated renal allograft rejection: new challenges for antiviral preventive strategies.Surrogate markers of infection: interrogation of the immune system.Valganciclovir to prevent or treat cytomegalovirus disease in organ transplantation.Opportunistic viral infections in intestinal transplantation.The efficacy and cost-effectiveness of valacyclovir in cytomegalovirus prevention in solid organ transplantation.Safety and Efficacy of Antiviral Therapy for Prevention of Cytomegalovirus Reactivation in Immunocompetent Critically Ill Patients: A Randomized Clinical Trial.Potential role of post-transplant hypogammaglobulinemia in the risk of Clostridium difficile infection after kidney transplantation: a case-control study.The use and value of procalcitonin in solid organ transplantation.Aging, cytomegalovirus (CMV) and influenza vaccine responses.Expanding role of cytomegalovirus as a human pathogen.The Cell Biology of Cytomegalovirus: Implications for Transplantation.Cytomegalovirus infection in lung transplant recipients.
P2860
Q21195897-C8597C51-AEA0-4F5B-814A-B4671E1C86BEQ26801802-FFAA4402-665E-4620-85BA-BC0445511BD7Q26824869-28BF3071-83BB-4C97-85B1-AD909DF09A71Q26863724-BA917F85-5DA4-46CF-B59E-EAF96CFC5998Q26996612-6F4CE7EE-2363-4D63-B5FF-2D952E34FBDFQ27003929-6B04D189-7CBC-487E-8C8E-107CC9AFDFBBQ27026492-36A71406-8EA2-41DF-B86C-70E4F526A466Q30430427-846FEF53-1137-4552-9377-B6ACA43219B0Q33714313-A26C2173-716C-4142-B940-8EBDE127CC66Q33768267-02B90E4E-1B90-4032-8EDD-6AC1051816A6Q33785269-7DF90AE9-F1FE-442C-8067-514C17E5E91BQ33912913-2BB81CE9-0D9B-41BD-9B5A-A9DBF9852776Q33916893-8915402A-D3A2-4661-AA3D-78AB30D4D232Q34162559-584C9902-DCA5-4015-8B7F-0E98962DFCE9Q34448341-25BCB03D-52C1-410D-9CB0-CAF01844AAC1Q34726933-C841B202-4F04-4F4D-A845-02C5E477E548Q35051236-777409FB-9157-4042-A5C4-61EF4712D0B6Q35078551-B3D06424-2215-4432-BFD2-A123EA00C5DDQ35134243-FFD3A9D6-3324-4CFC-B7CD-1FF2F7396E55Q35155784-5B2B769F-61A4-412C-AE43-516296A122CFQ36027654-9721E139-E3A7-4FB1-9C05-038CDAEFC4ACQ36126324-B458097F-7388-44EB-87AB-0A70490241DFQ36225887-33B62161-C0C8-48B5-8ED8-B0F7B31D68C8Q36979317-9AD1290B-E93E-43F9-8285-49DEE23E361FQ37015743-27B07302-1253-43E2-96BD-382AEC2B5355Q37359332-8C8E88ED-C58C-4EB4-9114-7B441D086A96Q37632938-DBDA146C-C634-427E-B38F-141195F30A49Q37726821-E6555E69-DF0A-40BD-8414-9FB77B104735Q37778827-478E4DB2-DA83-41EF-81EB-FE1C8D56FEC7Q37862743-5BEA2A56-A2F6-4503-AF1F-1DF0AFA9DC45Q37949634-4A5E46B0-A7D9-446B-8EC6-E49DCC4E3C0FQ38097119-47643133-B898-488C-9C5E-5C05C8868EBDQ38254037-58D5BA40-C118-4EED-A95F-AC7703034AA0Q38377602-AB9D0C43-230C-4C51-B045-E0ECB282FA41Q38416294-CC3144FE-1D6A-4EC2-A828-CB4A22E8E1AFQ38495375-F9F16A5B-4F2F-4082-9A74-663508F0B041Q38640148-58640CD2-1E95-4430-9C47-76B5C6EA5A9EQ38673038-BE9D1568-9FE8-4547-8144-AB5F5807E993Q38779938-BB1B4487-63DC-48AE-A250-2111DBD85EDAQ39226830-E8E4C6C9-3926-4301-AFF0-A1D879FE8D5D
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
The 'indirect' effects of cytomegalovirus infection.
@en
The 'indirect' effects of cytomegalovirus infection.
@nl
type
label
The 'indirect' effects of cytomegalovirus infection.
@en
The 'indirect' effects of cytomegalovirus infection.
@nl
prefLabel
The 'indirect' effects of cytomegalovirus infection.
@en
The 'indirect' effects of cytomegalovirus infection.
@nl
P1476
The 'indirect' effects of cytomegalovirus infection.
@en
P2093
R B Freeman
P2860
P304
P356
10.1111/J.1600-6143.2009.02824.X
P407
P577
2009-11-01T00:00:00Z